Found: 6
Select item for more details and to access through your institution.
Different mechanisms of acute versus long-term antihypertensive effects of soluble epoxide hydrolase inhibition: Studies in Cyp1a1-Ren-2 transgenic rats.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2014, v. 41, n. 12, p. 1003, doi. 10.1111/1440-1681.12310
- By:
- Publication type:
- Article
Inhibition of soluble epoxide hydrolase is renoprotective in 5/6 nephrectomized Ren-2 transgenic hypertensive rats.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2014, v. 41, n. 3, p. 227, doi. 10.1111/1440-1681.12204
- By:
- Publication type:
- Article
Inhibitors of soluble epoxide hydrolase minimize ischemia-reperfusion-induced cardiac damage in normal, hypertensive, and diabetic rats.
- Published in:
- Cardiovascular Therapeutics, 2017, v. 35, n. 3, p. n/a, doi. 10.1111/1755-5922.12259
- By:
- Publication type:
- Article
High calcium cementless fly ash binder with low environmental footprint: Optimum Taguchi design.
- Published in:
- Journal of the American Ceramic Society, 2019, v. 102, n. 4, p. 2203, doi. 10.1111/jace.15873
- By:
- Publication type:
- Article
Soluble epoxide hydrolase inhibitor, t-TUCB, protects against myocardial ischaemic injury in rats.
- Published in:
- Journal of Pharmacy & Pharmacology, 2014, v. 66, n. 9, p. 1251, doi. 10.1111/jphp.12251
- By:
- Publication type:
- Article
Inhibition of the Soluble Epoxide Hydrolase Promotes Albuminuria in Mice with Progressive Renal Disease.
- Published in:
- PLoS ONE, 2010, v. 5, n. 8, p. 1, doi. 10.1371/journal.pone.0011979
- By:
- Publication type:
- Article